The World Health Organization (WHO) warned about four cough and cold syrups produced by an Indian manufacturer on Wednesday, claiming they may have contributed to the deaths of 66 children in The Gambia. The cough and cold medications produced by Maiden Pharmaceuticals in Haryana may have caused serious kidney problems, according to the WHO. The WHO advised against using them in its advisory.
The four cough and cold medications—Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup—have been connected to the deaths of 66 children in The Gambia. The Indian manufacturer has not yet given guarantees about the safety and calibre of these products, according to a release from the WHO.
The WHO issued a medical product alert stating that “laboratory analysis of samples of each of the four items reveals that they contain excessive quantities of diethylene glycol and ethylene glycol as contaminants.” The WHO also cautioned that even though the items had only been discovered in The Gambia up until this point, they might have been exported to other nations.
